Polymyalgia Rheumatica Market Insights, Epidemiology, And Market Forecast-2030

Polymyalgia Rheumatica Market Insights, Epidemiology, And Market Forecast-2030

“DelveInsight Business Research LLP”
DelveInsight’s ‘Polymyalgia Rheumatica Market’ report deliver an in-depth understanding of the Polymyalgia Rheumatica (PMR), historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Polymyalgia Rheumatica Market

The Polymyalgia Rheumatica (PMR) market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted PMR symptoms market size from 2018 to 2030 segmented by seven major markets. The report also covers current Polymyalgia Rheumatica (PMR) symptoms treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Polymyalgia Rheumatica (PMR) Market Outlook

The Polymyalgia Rheumatica (PMR) market outlook of the report helps build a detailed comprehension of the historic, current, and forecasted Polymyalgia Rheumatica (PMR) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.

This segment gives a thorough detail of Polymyalgia Rheumatica (PMR) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on an annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Polymyalgia Rheumatica (PMR) market in 7MM is expected to change in the study period 2018–2030.

Key Findings

This section includes a glimpse of the Polymyalgia Rheumatica market in 7MM. The market size of PMR in the seven major markets was found to be USD 2,893.57 million in 2020, and the market is estimated to increase at a CAGR of 13.60% for the study period (2018–2030).

The United States Market Outlook

This section provides a total of Polymyalgia Rheumatica (PMR) market size and market size by therapies in the United States.

The United States accounts for the highest PMR market size compared to the EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.

EU-5 Countries: Market Outlook

The total Polymyalgia Rheumatica (PMR) market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

Japan Market Outlook

The total Polymyalgia Rheumatica (PMR) market size and market size by therapies in Japan are also mentioned.

Table of contents

1. Key Insights

2. Report Introduction

3. Polymyalgia Rheumatica Market Overview at a Glance

3.1. Market Share (%) Distribution of Polymyalgia Rheumatica in 2018

3.2. Market Share (%) Distribution of Polymyalgia Rheumatica in 2030

4. Executive Summary of Polymyalgia Rheumatica

5. Disease Background and Overview

5.1. Introduction

5.2. Symptoms

5.3. Etiology

5.4. Pathogenesis

5.5. Clinical Manifestation

5.6. Diagnosis

5.6.1. Classification Criteria

6. Management and Treatment of PMR

6.1. EULAR/ACR Recommendation

6.2. Treatment Algorithm

7. Epidemiology and Patient Population

7.1. Key Findings

7.2. 7MM Total Prevalent Patient Population of Polymyalgia Rheumatica

7.3. Epidemiology of Polymyalgia Rheumatica

7.4. The United States

7.4.1. Prevalence of Polymyalgia Rheumatica in the United States

7.4.2. Prevalent Cases of Polymyalgia Rheumatica based on clinical manifestation in the United States

7.4.3. Gender-specific Prevalence of Polymyalgia Rheumatic in the United States

7.4.4. Diagnosed Cases of GCA in PMR in the United States

7.5. EU5

7.5.1. Germany

7.5.2. France

7.5.3. Italy

7.5.4. Spain

7.5.5. United Kingdom

7.6. Japan

7.6.1. Prevalence of Polymyalgia Rheumatica in Japan

7.6.2. Prevalent Cases of Polymyalgia Rheumatica based on clinical manifestation in Japan

7.6.3. Gender-specific Prevalence of Polymyalgia Rheumatic in Japan

7.6.4. Diagnosed Cases of GCA in PMR in Japan

8. Organizations contributing towards Polymyalgia Rheumatica

9. Patient Journey

10. Case Reports

11. Emerging Therapies

11.1. Tocilizumab: Roche Chugai

11.1.1. Drug Description

11.1.2. Other Development Information

11.1.3. Clinical Development

11.1.4. Clinical Trials Information

11.1.5. Safety and Efficacy

11.1.6. Product Profile

11.2. Abatacept: Bristol-Myers Squibb

11.2.1. Drug Description

11.2.2. Other Development Information

11.2.3. Clinical Development

11.2.4. Clinical Trials Information

11.2.5. Product Profile

11.3. Baricitinib: Eli Lilly

11.3.1. Drug Description

11.3.2. Other Development Information

11.3.3. Clinical Development

11.3.4. Clinical Trials Information

11.3.5. Safety and Efficacy

11.3.6. Product Profile

12. Polymyalgia Rheumatica: 7 Major Market Analysis

12.1. Key Findings

12.2. Market Size of Polymyalgia Rheumatica in 7MM

12.3. Market Size of Polymyalgia Rheumatica by Therapies

13. Market Outlook

13.1. United States Market Size

13.1.1. Total Market Size of Polymyalgia Rheumatica in the United States

13.1.2. Market Size of Polymyalgia Rheumatica by Therapies in the United States

13.2. EU-5 Market Size

13.2.1. Germany

13.2.2. France

13.2.3. Italy

13.2.4. Spain

13.2.5. United Kingdom

13.3. Japan

13.3.1. Total Market size of Polymyalgia Rheumatica in Japan

13.3.2. Market Size of Polymyalgia Rheumatica by Therapies in Japan

14. KOL Views

15. Market Access

16. Market Drivers

17. Market Barriers

18. SWOT Analysis

19. Unmet Needs

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Request sample report of Polymyalgia Rheumatica Market Trends

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/